162 related articles for article (PubMed ID: 32583304)
1. The expression and functional analysis of the sialyl-T antigen in prostate cancer.
Bai R; Luan X; Zhang Y; Robbe-Masselot C; Brockhausen I; Gao Y
Glycoconj J; 2020 Aug; 37(4):423-433. PubMed ID: 32583304
[TBL] [Abstract][Full Text] [Related]
2. ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines.
Videira PA; Correia M; Malagolini N; Crespo HJ; Ligeiro D; Calais FM; Trindade H; Dall'Olio F
BMC Cancer; 2009 Oct; 9():357. PubMed ID: 19811634
[TBL] [Abstract][Full Text] [Related]
3. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cancer associated mucin type O-glycans using the exchange sialylation properties of mammalian sialyltransferase ST3Gal-II.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
J Proteome Res; 2012 Apr; 11(4):2609-18. PubMed ID: 22329400
[TBL] [Abstract][Full Text] [Related]
5. Mammalian sialyltransferase ST3Gal-II: its exchange sialylation catalytic properties allow labeling of sialyl residues in mucin-type sialylated glycoproteins and specific gangliosides.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
Biochemistry; 2011 Nov; 50(44):9475-87. PubMed ID: 21913655
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen carrying SLe
Gomes C; Almeida A; Barreira A; Calheiros J; Pinto F; Abrantes R; Costa A; Polonia A; Campos D; Osório H; Sousa H; Pinto-de-Sousa J; Kolarich D; Reis CA
Theranostics; 2019; 9(24):7431-7446. PubMed ID: 31695778
[TBL] [Abstract][Full Text] [Related]
7. α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues.
Pérez-Garay M; Arteta B; Llop E; Cobler L; Pagès L; Ortiz R; Ferri MJ; de Bolós C; Figueras J; de Llorens R; Vidal-Vanaclocha F; Peracaula R
Int J Biochem Cell Biol; 2013 Aug; 45(8):1748-57. PubMed ID: 23726834
[TBL] [Abstract][Full Text] [Related]
8. alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo.
Pérez-Garay M; Arteta B; Pagès L; de Llorens R; de Bolòs C; Vidal-Vanaclocha F; Peracaula R
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824144
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the specificity of sialyltransferases toward mucin core 2, globo, and related structures. identification of the sialylation sequence and the effects of sulfate, fucose, methyl, and fluoro substituents of the carbohydrate chain in the biosynthesis of selectin and siglec ligands, and novel sialylation by cloned alpha2,3(O)sialyltransferase.
Chandrasekaran EV; Xue J; Xia J; Chawda R; Piskorz C; Locke RD; Neelamegham S; Matta KL
Biochemistry; 2005 Nov; 44(47):15619-35. PubMed ID: 16300412
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.
Sproviero D; Julien S; Burford B; Taylor-Papadimitriou J; Burchell JM
J Biol Chem; 2012 Dec; 287(53):44490-7. PubMed ID: 23275522
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of α2,3-linked sialic acids promotes gastric cancer cell metastasis and correlates with poor prognosis.
Shen L; Luo Z; Wu J; Qiu L; Luo M; Ke Q; Dong X
Int J Oncol; 2017 Apr; 50(4):1201-1210. PubMed ID: 28259967
[TBL] [Abstract][Full Text] [Related]
12. Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-κB-dependent transcriptional control of α2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells.
Hatano K; Miyamoto Y; Nonomura N; Kaneda Y
Int J Cancer; 2011 Oct; 129(8):1838-47. PubMed ID: 21165949
[TBL] [Abstract][Full Text] [Related]
13. Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation.
Martin LT; Marth JD; Varki A; Varki NM
J Biol Chem; 2002 Sep; 277(36):32930-8. PubMed ID: 12068010
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of sialyltransferases ST6GAL-I and ST3GAL-III in gastric cancer.
Gretschel S; Haensch W; Schlag PM; Kemmner W
Oncology; 2003; 65(2):139-45. PubMed ID: 12931020
[TBL] [Abstract][Full Text] [Related]
15. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
[TBL] [Abstract][Full Text] [Related]
17. Sialyl-Lewis(x) on P-selectin glycoprotein ligand-1 is regulated during differentiation and maturation of dendritic cells: a mechanism involving the glycosyltransferases C2GnT1 and ST3Gal I.
Julien S; Grimshaw MJ; Sutton-Smith M; Coleman J; Morris HR; Dell A; Taylor-Papadimitriou J; Burchell JM
J Immunol; 2007 Nov; 179(9):5701-10. PubMed ID: 17947642
[TBL] [Abstract][Full Text] [Related]
18. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
Scott E; Archer Goode E; Garnham R; Hodgson K; Orozco-Moreno M; Turner H; Livermore K; Putri Nangkana K; Frame FM; Bermudez A; Jose Garcia Marques F; McClurg UL; Wilson L; Thomas H; Buskin A; Hepburn A; Duxfield A; Bastian K; Pye H; Arredondo HM; Hysenaj G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Heer R; Maitland NJ; Whitaker H; Pitteri S; Troyer DA; Wang N; Elliott DJ; Drake RR; Munkley J
J Pathol; 2023 Sep; 261(1):71-84. PubMed ID: 37550801
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of ST3Gal-I promotes mammary tumorigenesis.
Picco G; Julien S; Brockhausen I; Beatson R; Antonopoulos A; Haslam S; Mandel U; Dell A; Pinder S; Taylor-Papadimitriou J; Burchell J
Glycobiology; 2010 Oct; 20(10):1241-50. PubMed ID: 20534593
[TBL] [Abstract][Full Text] [Related]
20. The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis.
Priatel JJ; Chui D; Hiraoka N; Simmons CJ; Richardson KB; Page DM; Fukuda M; Varki NM; Marth JD
Immunity; 2000 Mar; 12(3):273-83. PubMed ID: 10755614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
